Description 

Key Characteristics of Pharma Test E 300

Pharma Test E 300 is an injectable AAS that contains Testosterone Enanthate at a concentration of 300 mg/mL. It serves as a synthetic version of the body’s primary natural male hormone, testosterone.

Ester Type: Enanthate is a slow-release ester.

Half-Life: It has a half-life of approximately 5 to 7 days.

Injection Frequency: Usually injected once or twice a week to maintain stable blood levels.

Concentration: At 300 mg/mL, it is slightly more concentrated than the standard medical grade (which is typically 200 mg/mL or 250 mg/mL)

Medical (TRT): Used to treat primary and hypogonadotropic hypogonadism (low T). It is preferred by many patients because it requires fewer injections than Testosterone Propionate.

Bodybuilding/Athletics: Used as a “base” for muscle-building cycles. Because it promotes water retention and nitrogen storage, it is often favored for “bulking” phases rather than “cutting”.

 

Pharmacokinetics & Mechanism of Action

Testosterone Enanthate is an esterified variant of testosterone. The enanthate ester is attached via a 17-beta hydroxyl group, making the compound highly hydrophobic (oil-soluble).

• The Release Window: Once injected into muscle tissue, the oil forms a “depot.” Enzymes called esterases slowly cleave the ester bond over time, releasing free testosterone into the bloodstream.

• Blood Concentration Spikes: Peak testosterone levels are reached within 24 to 48 hours post-injection, followed by a gradual decline over a 7- to 10-day period.

• Pip (Post-Injection Pain): Because this formulation is highly concentrated (300 mg/mL compared to the standard clinical 200–250 mg/mL), users frequently report higher localized inflammation, soreness, or “bite” at the injection site due to the higher density of the hormone and solvent profile.

Protocol Dynamics: Clinical vs. Performance Use

The management of this compound changes drastically depending on the intent behind its use:

1. Clinical Hormone Replacement Therapy (TRT)

 

In a certified clinical setting, the objective is physiological replacement (bringing a patient from hypogonadal to normal levels: ~300 to 1,000 ng/dL).

• Standard TRT Dosing: Usually 100 mg to 150 mg per week.

• Using 300 mg/mL: For a 100 mg dose, a patient would only draw 0.33 mL of fluid.

• Frequency: Medical literature historically recommended large doses every 2 to 3 weeks, but modern endocrinology favors splitting the dose into 1 to 2 injections per week (e.g., 50 mg twice a week) to prevent dramatic hormonal peaks and valleys.

 

2. Performance Enhancement / Supraphysiological Cycles

 

In bodybuilding or athletic contexts, doses exceed natural replacement thresholds to maximize anabolic pathways.

• Anabolic Dosing: Ranges from 300 mg to 500 mg per week, administered over cycles lasting 10 to 12 weeks.

• Frequency: Injected twice weekly (e.g., 150 mg on Monday, 150 mg on Thursday) to stabilize serum concentrations and mitigate massive estrogenic spikes.

For more compounds like this, visit Phama Test C 250

 

Product Parameter	Technical Specification & Core Data
Packaging & Size	Multi-dose liquid glass vial containing exactly 10 mL of total fluid.
Active Substance	Testosterone Enanthate.
Concentration Strength	300 mg / mL (Providing 3,000 mg of total hormone per vial).
Base Carrier Oil	Refined Castor Oil or Grape Seed Oil (Creates the dense liquid depot in the muscle).
Chemical Preservatives	Benzyl Benzoate (solubilizing agent) and Benzyl Alcohol (antimicrobial preservative).
Active Half-Life	4.5 to 5 days (Total release window spans roughly 7–10 days).
Anabolic/Androgenic Ratio	100 : 100 (The human physiological baseline standard for comparisons).
Primary Use	Mass-building base for athletic cycles, or severe testosterone hypogonadism correction.
Injection Method	Intramuscular (IM) injection only (typically using a 23G to 25G syringe needle).